Environmental

No disclosed R&D intensity or emissions metrics are provided, limiting peer comparison on transition readiness versus more transparent healthcare peers.

Zero reported gross profit margin in the supplied metrics suggests limited operating flexibility to fund environmental initiatives, unlike better-capitalized peers.

The absence of capitalized R&D disclosure reduces visibility into product stewardship and resource-efficiency efforts relative to peers with clearer sustainability reporting.

Low net debt to EBITDA indicates balance-sheet capacity for environmental compliance spending, but this advantage is less informative without peer-disclosed environmental targets.

Social

No workforce, safety, or patient-outcome metrics are provided, so social positioning cannot be verified against peers with more complete disclosure.

Zero stock-based compensation to revenue may indicate limited equity-linked retention pressure, but it does not substitute for evidence on talent stability versus peers.

The lack of disclosed R&D spending constrains assessment of product quality and access-related social commitments relative to more transparent healthcare companies.

Overall social risk appears moderate because disclosure gaps, rather than identified controversies, are the main factor limiting peer-relative confidence.

Governance

A debt-to-equity ratio of 32.0x is materially higher than typical peers, increasing governance scrutiny around capital discipline and financing oversight.

Net debt to EBITDA is low, which partially offsets leverage concerns, but the extreme equity leverage still weakens relative governance resilience.

Zero stock-based compensation to revenue suggests limited dilution pressure, yet it also provides little evidence of strong incentive alignment versus peers.

Sparse disclosure across compensation, capital allocation, and operating metrics leaves governance quality harder to verify than for better-reporting peers.

Overall Score

SLXN screens as a moderate ESG name because limited disclosure and elevated equity leverage outweigh the small balance-sheet advantage versus peers.

Score Driver: High Debt-To-Equity Leverage Relative To Peers